Hirotaka Nakagawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hirotaka Nakagawa has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Walter I. Sussman
Tufts University Boston Massachusetts USA
6 shared publications - Judy Rabinowitz
Hirsch Health Sciences Library Tufts University Boston Massachusetts USA
2 shared publications - Robert L. Bowers
Department of Orthopaedics Emory University School of Medicine Atlanta Georgia USA
2 shared publications Tabitha May
Department of Radiation Oncology, UMass Chan Medical School, 55 N Lake Ave, Worcester, MA01655, USA
2 shared publicationsE. Nakano
The University of Tokyo
1 shared publication- Erek Latzka
Boston Sports & Biologics Wellesley Massachusetts USA
1 shared publication
Latest Publications
Assessment of adverse events and safety associated with intra‐articular platelet‐rich plasma injections compared to other injectates for knee osteoarthritis: A systematic review and meta‐analysis
Objective: To evaluate adverse events (AEs) associated with intra‐articular platelet‐rich plasma (IA‐PRP) injections for knee osteoarthritis (KOA) and compare their rates with those of intra‐articular corticosteroids (IA‐CS), hyaluronic acid (IA‐HA), and normal saline (IA‐NS). Literature Survey: A systematic search of PubMed, Embase, and Cochrane Library databases identified randomized controlled trials (RCTs) published after 2015. Studies were included if they reported AEs related to IA‐PRP injections for KOA and provided comparator data for IA‐CS, IA‐HA, or IA‐NS. Methodology: Data on AEs were extracted and categorized into mild knee pain and swelling, severe knee pain requiring withdrawal, knee stiffness, other musculoskeletal (MSK) events, non‐MSK events, and severe AEs. A random‐effects meta‐analysis was performed to calculate odds ratios (OR) with 95% confidence intervals (CI) for AE rates in IA‐PRP versus comparator groups. Subgroup analysis was conducted to evaluate the effects of leukocyte concentration on AE rates. Synthesis: Thirty‐two RCTs published articles, involving 1268 IA‐PRP‐treated knees, met inclusion criteria. AEs were reported in 18.7% of IA‐PRP cases, with mild knee pain and swelling being the most common (10.6%). Compared to IA‐HA, IA‐PRP had significantly higher rates of mild knee pain and swelling ( p < .001). Subgroup analysis revealed that this difference was significant only for leukocyte‐rich IA‐PRP ( p < .05), whereas leukocyte‐poor IA‐PRP showed no significant difference compared to IA‐HA ( p = .51). Knee stiffness was more frequent in IA‐PRP versus IA‐NS ( p = .031). There were no significant differences in other AE categories, and no severe AEs were reported across any groups. Conclusions: IA‐PRP injections are associated with mild, transient AEs such as knee pain and swelling, particularly with leukocyte‐rich PRP formulations. These symptoms typically resolve without intervention. Leukocyte‐poor IA‐PRP showed a similar safety profile to IA‐HA. No severe AEs were observed, supporting the overall safety of IA‐PRP for KOA. Clinicians should counsel patients on the likelihood of mild postprocedure symptoms, especially with high leukocyte formulations, while considering IA‐PRP as a treatment option.
Assessment of adverse events and safety associated with intra‐articular platelet‐rich plasma injections compared to other injectates for knee osteoarthritis: A systematic review and meta‐analysis
Objective: To evaluate adverse events (AEs) associated with intra‐articular platelet‐rich plasma (IA‐PRP) injections for knee osteoarthritis (KOA) and compare their rates with those of intra‐articular corticosteroids (IA‐CS), hyaluronic acid (IA‐HA), and normal saline (IA‐NS). Literature Survey: A systematic search of PubMed, Embase, and Cochrane Library databases identified randomized controlled trials (RCTs) published after 2015. Studies were included if they reported AEs related to IA‐PRP injections for KOA and provided comparator data for IA‐CS, IA‐HA, or IA‐NS. Methodology: Data on AEs were extracted and categorized into mild knee pain and swelling, severe knee pain requiring withdrawal, knee stiffness, other musculoskeletal (MSK) events, non‐MSK events, and severe AEs. A random‐effects meta‐analysis was performed to calculate odds ratios (OR) with 95% confidence intervals (CI) for AE rates in IA‐PRP versus comparator groups. Subgroup analysis was conducted to evaluate the effects of leukocyte concentration on AE rates. Synthesis: Thirty‐two RCTs published articles, involving 1268 IA‐PRP‐treated knees, met inclusion criteria. AEs were reported in 18.7% of IA‐PRP cases, with mild knee pain and swelling being the most common (10.6%). Compared to IA‐HA, IA‐PRP had significantly higher rates of mild knee pain and swelling ( p < .001). Subgroup analysis revealed that this difference was significant only for leukocyte‐rich IA‐PRP ( p < .05), whereas leukocyte‐poor IA‐PRP showed no significant difference compared to IA‐HA ( p = .51). Knee stiffness was more frequent in IA‐PRP versus IA‐NS ( p = .031). There were no significant differences in other AE categories, and no severe AEs were reported across any groups. Conclusions: IA‐PRP injections are associated with mild, transient AEs such as knee pain and swelling, particularly with leukocyte‐rich PRP formulations. These symptoms typically resolve without intervention. Leukocyte‐poor IA‐PRP showed a similar safety profile to IA‐HA. No severe AEs were observed, supporting the overall safety of IA‐PRP for KOA. Clinicians should counsel patients on the likelihood of mild postprocedure symptoms, especially with high leukocyte formulations, while considering IA‐PRP as a treatment option.
- 18 February 2026
- Published by BMJ in British Journal of Sports Medicine
- Vol. 60 (5) , 370-378
Effects of percutaneous platelet-rich plasma injection on return-to-play after acute hamstring muscle injury: a systematic review and meta-analysis
Objective: To evaluate the effectiveness and safety of platelet-rich plasma (PRP) for acute hamstring injuries, with attention to return-to-play (RTP) time, reinjury rates and adverse events. Design: Systematic review and meta-analysis of randomised controlled trials (RCTs). Risk of bias was assessed using the Cochrane tool; certainty of evidence was evaluated using GRADE (Grading of Recommendations Assessment, Development and Evaluation). Data sources: Databases included Embase, MEDLINE, Web of Science, Elsevier and Cochrane Central searched through March 2025. Eligibility criteria: RCTs comparing PRP to control treatments for acute hamstring injuries were included. Non-randomised and chronic tendinopathy studies were excluded. Results: Six RCTs (n=277) were included. PRP reduced RTP time versus control (mean difference –8.6 days; 21.4 vs 30.0 days; 95% CI –3.04 to –0.03; p=0.045), though heterogeneity was high (I²=94.1%). Reinjury (15% vs 16%; p=0.722) and adverse event rates (1% vs 0%; p=0.687) did not differ. Certainty of evidence was rated as low to moderate due to risk of bias and imprecision. Conclusion: PRP may shorten RTP in acute hamstring injuries, especially when image-guided. Reinjury risk appears unchanged. Further trials are needed to confirm these findings and standardise biological use in muscle injuries. PROSPERO registration number: CRD420251109346.
- 18 February 2026
- Published by BMJ in British Journal of Sports Medicine
- Vol. 60 (5) , 370-378
Effects of percutaneous platelet-rich plasma injection on return-to-play after acute hamstring muscle injury: a systematic review and meta-analysis
Objective: To evaluate the effectiveness and safety of platelet-rich plasma (PRP) for acute hamstring injuries, with attention to return-to-play (RTP) time, reinjury rates and adverse events. Design: Systematic review and meta-analysis of randomised controlled trials (RCTs). Risk of bias was assessed using the Cochrane tool; certainty of evidence was evaluated using GRADE (Grading of Recommendations Assessment, Development and Evaluation). Data sources: Databases included Embase, MEDLINE, Web of Science, Elsevier and Cochrane Central searched through March 2025. Eligibility criteria: RCTs comparing PRP to control treatments for acute hamstring injuries were included. Non-randomised and chronic tendinopathy studies were excluded. Results: Six RCTs (n=277) were included. PRP reduced RTP time versus control (mean difference –8.6 days; 21.4 vs 30.0 days; 95% CI –3.04 to –0.03; p=0.045), though heterogeneity was high (I²=94.1%). Reinjury (15% vs 16%; p=0.722) and adverse event rates (1% vs 0%; p=0.687) did not differ. Certainty of evidence was rated as low to moderate due to risk of bias and imprecision. Conclusion: PRP may shorten RTP in acute hamstring injuries, especially when image-guided. Reinjury risk appears unchanged. Further trials are needed to confirm these findings and standardise biological use in muscle injuries. PROSPERO registration number: CRD420251109346.
- 26 November 2024
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 19 (11) , 529-539
Bone marrow aspirate concentrate for the treatment of fifth metatarsal head stress fracture: a case report
Metatarsal head stress fractures pose treatment challenges with no established consensus. In this article, we introduce a percutaneous treatment involving autologous bone marrow aspirate concentrate (BMAC) injection without surgical fixation in a 21-year-old basketball player with a stress fracture of the right fifth metatarsal head. He underwent this procedure following unsuccessful 8 months of conservative treatment. Twelve weeks after the procedure, a CT scan confirmed complete healing, facilitating his return to sports. This innovative method offers a promising alternative, avoiding the associated morbidity of surgical intervention. Further research, comparing refracture rates with surgical options, is warranted to inform treatment decisions for this uncommon injury and validate the efficacy of percutaneous BMAC injection.
- 26 November 2024
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 19 (11) , 529-539
Bone marrow aspirate concentrate for the treatment of fifth metatarsal head stress fracture: a case report
Metatarsal head stress fractures pose treatment challenges with no established consensus. In this article, we introduce a percutaneous treatment involving autologous bone marrow aspirate concentrate (BMAC) injection without surgical fixation in a 21-year-old basketball player with a stress fracture of the right fifth metatarsal head. He underwent this procedure following unsuccessful 8 months of conservative treatment. Twelve weeks after the procedure, a CT scan confirmed complete healing, facilitating his return to sports. This innovative method offers a promising alternative, avoiding the associated morbidity of surgical intervention. Further research, comparing refracture rates with surgical options, is warranted to inform treatment decisions for this uncommon injury and validate the efficacy of percutaneous BMAC injection.
- 4 July 2023
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 42 (11) , 2491-2499
Ultrasound‐Guided A1 Pulley Release: A Systematic Review
The purpose of this review was to summarize the current literature pertaining to ultrasound‐guided percutaneous A1 pulley release procedures. We searched PubMed, Cochrane Library, Embase, and Web of Science for clinical studies examining ultrasound‐guided percutaneous A1 pulley release. A total of 17 studies involving 749 procedures were included in this review. The overall success rate was 97%. There were 23 minor complications (4 cases of hematomas, 15 cases of persistent pain, and 4 cases of transient numbness) and no major complications reported. Ultrasound‐guided A1 pulley release is an effective and safe procedure for the treatment of trigger fingers and thumb.
- 4 July 2023
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 42 (11) , 2491-2499
Ultrasound‐Guided A1 Pulley Release: A Systematic Review
The purpose of this review was to summarize the current literature pertaining to ultrasound‐guided percutaneous A1 pulley release procedures. We searched PubMed, Cochrane Library, Embase, and Web of Science for clinical studies examining ultrasound‐guided percutaneous A1 pulley release. A total of 17 studies involving 749 procedures were included in this review. The overall success rate was 97%. There were 23 minor complications (4 cases of hematomas, 15 cases of persistent pain, and 4 cases of transient numbness) and no major complications reported. Ultrasound‐guided A1 pulley release is an effective and safe procedure for the treatment of trigger fingers and thumb.
- 11 May 2023
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 18 (5) , 399-411
Lateral Epicondylitis: Comparing Ultrasound-Guided Tenotomy with or without Amniotic Membrane Allograft Injection
Aim: To evaluate the clinical response to augmenting ultrasound-guided tenotomy (USGT) with an amniotic membrane (AM) allograft injection. Design: Retrospective study. Materials & methods: Subjects... Plain language summary The goal of this study was to determine if a single injection of an amniotic membrane (AM) tissue improves clinical outcomes for patients with chronic tennis elbow treated wi... Tweetable abstract In this study, researchers found that the addition of an amniotic membrane injection does not result in quicker or greater pain relief when used to augment tennis elbow surgery w...
- 11 May 2023
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 18 (5) , 399-411
Lateral Epicondylitis: Comparing Ultrasound-Guided Tenotomy with or without Amniotic Membrane Allograft Injection
Aim: To evaluate the clinical response to augmenting ultrasound-guided tenotomy (USGT) with an amniotic membrane (AM) allograft injection. Design: Retrospective study. Materials & methods: Subjects... Plain language summary The goal of this study was to determine if a single injection of an amniotic membrane (AM) tissue improves clinical outcomes for patients with chronic tennis elbow treated wi... Tweetable abstract In this study, researchers found that the addition of an amniotic membrane injection does not result in quicker or greater pain relief when used to augment tennis elbow surgery w...
- 12 October 2022
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 17 (12) , 931-940
Plantar Fasciitisc: A Comparison of Ultrasound-Guided Fasciotomy With or Without Amniotic Membrane Allograft Injection
Aim: The purpose of this study was to evaluate the clinical response to augmenting an ultrasound-guided percutaneous plantar fasciotomy (UGPF) with an amniotic membrane (AM) allograft injection. De... Plain language summary The purpose of this study was to determine if a single injection of an amniotic membrane (AM) tissue injection improves pain and satisfaction scores for patients with chronic... Tweetable abstract In a preliminary study, researchers found that amniotic membrane injections may provide faster pain relief when injected into the plantar fasciotomy during surgery.
- 12 October 2022
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 17 (12) , 931-940
Plantar Fasciitisc: A Comparison of Ultrasound-Guided Fasciotomy With or Without Amniotic Membrane Allograft Injection
Aim: The purpose of this study was to evaluate the clinical response to augmenting an ultrasound-guided percutaneous plantar fasciotomy (UGPF) with an amniotic membrane (AM) allograft injection. De... Plain language summary The purpose of this study was to determine if a single injection of an amniotic membrane (AM) tissue injection improves pain and satisfaction scores for patients with chronic... Tweetable abstract In a preliminary study, researchers found that amniotic membrane injections may provide faster pain relief when injected into the plantar fasciotomy during surgery.
- 1 January 2013
- Published by Springer Nature
- p. 1961-1964
Development of an Implantable Small Observation Camera with Scaffold Chamber for Angiogenesis
- 1 January 2013
- Published by Springer Nature
- p. 1961-1964
Development of an Implantable Small Observation Camera with Scaffold Chamber for Angiogenesis
- 1 September 2004
- Published by Elsevier in Surface Science
- Vol. 566-568, 425-429
Nano-cluster formation in halogen etching on Cl/Si(111)-7×7
- 1 September 2004
- Published by Elsevier in Surface Science
- Vol. 566-568, 425-429
Nano-cluster formation in halogen etching on Cl/Si(111)-7×7